Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active... – Polymer from ethylenic monomers only
Patent
1983-06-14
1986-02-18
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Solid synthetic organic polymer as designated organic active...
Polymer from ethylenic monomers only
424 19, 514570, A61K 922, A61K 926
Patent
active
045713332
ABSTRACT:
A controlled release tablet for once-daily oral administration of about 500-1200 mg of naproxen or naproxen sodium, said tablet being a homogeneous matrix comprising about 4-9 weight percent of hydroxypropylmethylcellulose having a number average molecular weight in the range of from about 80,000 to about 130,000, about 81-96 weight percent naproxen or naproxen sodium, 0.1 to about 2 weight percent of a pharmacetucailly acceptable lubricating agent, and 0 to about 8 weight percent of other pharmaceutically acceptable excipients.
REFERENCES:
patent: 3065143 (1962-11-01), Christenson et al.
patent: 3424842 (1969-01-01), Nurnberg
patent: 3807790 (1975-03-01), Lowey et al.
patent: 4226849 (1980-10-01), Schor
patent: 4369172 (1983-01-01), Schor et al.
patent: 4389393 (1983-06-01), Schor et al.
Chowhan et al. J. Pharm. Sci. 70(10): 1134-1139 Oct. 1981 Compression Properties of Granulations Made with Binders Containing Different Moisture Contents, (7.8% HPMC Table 1, p. 1135).
Chowhan J. Pharm. Sci. 69(1): 1-4 Jan. 1980 Role of Binders in Moisture-Induced Hardness Increase in Compressed Tablets and its Effect on in vitro Disintegeration and Dissolution, HPMC 10% Table I, p. 2.
Chowhan J. Pharm. Sci. 67(10): 1385-1389 (Oct. 1978) Hardness Increase Induced by Partial Moisture Loss in Compressed Tablets and its Effect on in vitro Dissolution Naproxen, Naproxen Sodium 2% HPMC "F", p. 1386, Table I.
.COPYRGT.1982 Dow Chemical Co., "Formulating Sustained Release Pharmaceutical Products with Methocel* (Trademark, Dow Chemical Co.), Form. No. 192-869-782, 10% HPMC, 22 pages.
Lapidus, Herbert, Ph.D Dissertation, Rutgers, 1967, Drug Release from Compressed Hydrophilic Materials, p. 103 Table IX 2.6 to 21.4% HPMC, p.107, 11.8% HPMC, p. 50 1582 Univ. Microfilms Int., Ann Arbor, Mich., Table III, 167, 66.6,83.4% HPMC.
Lapidus et al., J. Pharm. Sci., vol. 55, No. 8, pp. 840-843, (1966), ("Lapidus I").
Lapidus et al., J. Pharm. Sci., vol. 57, No. 8, pp. 1292-1308, (1968) ("Lapidus II").
Salomon et al., Pharm. Acta. Hevl., vol. 54, No. 3, pp. 82-85 (1975), (English Translation to be provided).
Borzunov, E., Farmatsevtichinii Zhurnal, Kiev, vol. 25(5) 1970, pp. 76-77.
Davis, S. S. et al., "Scintigraphic Studies on the in vivo Dissolution of a Buccal Tablet", in Modern Concepts in Nitrate Delivery Systems, Ed. by A. A. J. Goldberg and D. J. Parsons, 1983: Royal Society of Medicine International Congress and Symposium Series No. 54, pp. 30-37.
Kassem, A. A., "Enhancement of Release Rate of Spirolactone from Tablets by Formation of Solid Dispersions with Water-Soluble Polymers", Bulletin of the Faculty of Pharmacy, Cairo University, vol. 19(1), 1980, pp. 275-307.
Gudsoorkar, V. R., and Khanna, S., "Influence of Binders on Some Physical Parameters of Lactose and Sulfadimidine Tablets", Indian Drugs and Pharmaceuticals Industry, vol. 15(4), 1980, pp. 3-5.
Korsmeyer, R. W., et al., "Mechanisms of Potassium Chloride Release for Compressed, Hydrophilic, Polymeric Matrices: Effect of Entrapped Air", Journal of Pharmaceutical Science, vol. 72(10) 1983, pp. 1189-1191.
Krycer, I. and Pope, D. G., "An Evaluation of Tablet Binding Agents, Part II, Pressure Binders", Powder Technology, vol. 34(1) 1983, pp. 53-56.
Ibid, pp. 39-51.
Laguna, O. et al., "Enrobage.-III, Influence de Quelques Produits Filmogenes at Plastifiants sur la Dissolution de Comprimes a Base de Chlorure de Sodium", Annales Pharecutiques Francaises, 1975, vol. 33(5), pp. 235-242.
Malkowska, S. et al., "Effect of Re-Compression on the Properties of Tablets Prepared by Moist Granulation", Drug Development and Industrial Pharmacy, 9(3), pp. 349-361, (1983).
Miseta, M. "Influence of Pressing Force on the Physical Features of Sulfathiazole Tablets and on the Dissolution Rate of Active Ingredient:, Pharmazie, vol. 38(5), 1983, pp. 326-327.
Miseta, M. "Die Beziehung Zwischen Preskraft und Rollfestigkeit bei Sulfaethidol-Tabletten", Pharmazie, vol. 38(8), 1983, p. 577.
Nagy, G. et al., "Untersuchungen uber die Textur und die Eigenschaften von Acetyl-Salicylsaure-Tabletten", Pharmazie, vol. 33(11), 1978, pp. 747-749.
Pintye-Hodi, K., et al., "Untersuchungen uber die Textur und die Engenschaften von Acetyl-Salicylsaure-Tabletten", Pharmazie, vol. 35(3), 1980, pp. 168-170.
Solomon, J. L. et al., "Sustained Release of Water Soluble Drug from Hydrophilic Compressed Dosage Forms", Pharm. Ind., vol. 41(8), 1979, pp. 799-802.
Hsiao Charles H.
Kent John S.
Buckles Ellen J.
Krubiner Alan M.
Moran Tom M.
Rose Shep K.
Syntex (U.S.A.) Inc.
LandOfFree
Controlled release naproxen and naproxen sodium tablets does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled release naproxen and naproxen sodium tablets, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release naproxen and naproxen sodium tablets will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1550556